Jaime Rodriguez-Canales
Jaime Rodriguez-Canales
Verified email at - Homepage
Cited by
Cited by
Pancreatic cancer
D Li, K Xie, R Wolff, JL Abbruzzese
The Lancet 363 (9414), 1049-1057, 2004
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...
Cancer discovery 8 (7), 822-835, 2018
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...
The Lancet Oncology 18 (11), 1493-1501, 2017
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic …
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
XP Yang, K Ghoreschi, SM Steward-Tharp, J Rodriguez-Canales, J Zhu, ...
Nature immunology 12 (3), 247-254, 2011
Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma
FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, ...
Journal of clinical oncology 36 (14), 1419, 2018
A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition
MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ...
Clinical Cancer Research 22 (3), 609-620, 2016
Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16–related cancer: a phase 2 clinical trial
E Massarelli, W William, F Johnson, M Kies, R Ferrarotto, M Guo, L Feng, ...
JAMA oncology 5 (1), 67-73, 2019
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ...
Cancer discovery 8 (9), 1156-1175, 2018
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
J Kim, Z Hu, L Cai, K Li, E Choi, B Faubert, D Bezwada, ...
Nature 546 (7656), 168-172, 2017
Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues
ER Parra, N Uraoka, M Jiang, P Cook, D Gibbons, MA Forget, ...
Scientific reports 7 (1), 13380, 2017
Diagnosis and molecular classification of lung cancer
J Rodriguez-Canales, E Parra-Cuentas, II Wistuba
Lung Cancer: Treatment and Research, 25-46, 2016
Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis
MS Padanad, G Konstantinidou, N Venkateswaran, M Melegari, S Rindhe, ...
Cell reports 16 (6), 1614-1628, 2016
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
I Petrini, PS Meltzer, IK Kim, M Lucchi, KS Park, G Fontanini, J Gao, ...
Nature genetics 46 (8), 844-849, 2014
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
J Kim, E McMillan, HS Kim, N Venkateswaran, G Makkar, ...
Nature 538 (7623), 114-117, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
H Kadara, M Choi, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ...
Annals of Oncology 28 (1), 75-82, 2017
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
DH Peng, C Ungewiss, P Tong, LA Byers, J Wang, JR Canales, ...
Oncogene 36 (14), 1925-1938, 2017
Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases
H Shao, L Xi, M Raffeld, AL Feldman, RP Ketterling, R Knudson, ...
Modern Pathology 24 (11), 1421-1432, 2011
The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ...
Journal for immunotherapy of cancer 8 (1), 2020
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
SC Tripathi, HL Peters, A Taguchi, H Katayama, H Wang, A Momin, ...
Proceedings of the National Academy of Sciences 113 (11), E1555-E1564, 2016
The system can't perform the operation now. Try again later.
Articles 1–20